SecBot SecBot

ILMN

ILLUMINA, INC.
Nasdaq· Laboratory Analytical Instruments· Inc. DE· CIK 0001110803 Genomics & Gene Editing
$198.00 −9.01 (−4.35%)
Nov 16 4:00 PM ET · prev $207.01
Market cap
$31.7B
Large cap
Consensus
Buy
54% Buy or better · 28 analysts
Median target
$272.50
+38% · range $165.00–365.00
1 year
+64.9%
from $120.08 · Nov 17
30 days
−24.6%
from $262.66
52-week range
$114.44–293.69
−33% from high · low Feb 12
Avg volume 20D
2.21M
shares / day
Short interest
8.02M
≈5.3% of shares · +1.7%
Days to cover
3.7
at average volume
Insider net
−$155.3M
0 buyers · 2 sellers · since Sep 3
New fund stakes
8
Q3 2026 13F · 2 exits
Reddit crowd
50°
Neutral · 1 mention this week
SecBot read BULLISH 17 reports · 90 days
Balance 2 bearish · 5 bullish · 1 mixed · 9 neutral oldest → newest, height = score
Avg score ·High conf. 12/17

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    2 insiders sold $155.3M.

  • InstitutionsBULLISH

    Q3 2026: 88 added (8 new), 39 trimmed or exited.

  • AnalystsBULLISH

    15 of 28 rate it Buy or better. Median target $272.50 (+38%).

  • Short sellersSTEADY

    Short interest +1.7% to 8.02M shares. 3.7 days to cover, ≈5.3% of shares.

  • TrendDOWNTREND

    20% below its 50-day average.

  • SocialQUIET

    Crowd 50° (neutral) this week from 1 mention: 0 bullish, 0 bearish. No setup is alerting.

Who's buying

13F· Q3 2026
8
new positions
2
exits
FundMoveSharesValue
FMR LLCDOUBLED16,186,139$4.4B
VANGUARD CAPITAL MANAGEMENT LLCADD9,886,477$2.7B
Capital World InvestorsTRIM9,884,439$2.7B
JPMORGAN CHASE & CODOUBLED4,942,580$1.3B
GEODE CAPITAL MANAGEMENT, LLCADD4,220,266$1.2B
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPDOUBLED1,615,818$442.2M
Ninety One UK LtdDOUBLED1,359,974$372.2M
UBS Group AGADD1,233,198$337.5M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

28 analysts
Buy 54% rate it Buy or better
Strong Buy6Buy9Hold10Sell2Strong Sell1
12-month targets · 20 analysts

Price is inside the target range. Median implies +38%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Nov 2, 2026Citigroup
MAINTAIN
MAINTAINSell
Oct 30, 2026JP Morgan
MAINTAIN
MAINTAINOverweight
Oct 30, 2026Evercore ISI Group
MAINTAIN
MAINTAINOutperform
Oct 19, 2026Canaccord Genuity
MAINTAIN
MAINTAINHold
Oct 13, 2026TD Cowen
MAINTAIN
MAINTAINHold
Oct 7, 2026Barclays
MAINTAIN
MAINTAINUnderweight

Washington

Corporate Lobbying

55 lobbying filings and 4 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Insider ledger

Form 4
$0
bought · 0 insiders
$155.3M
sold · 2 insiders
DateInsiderTypeValue
Nov 11, 2026
Meister Keith A.
Director
Nov 11, 2026
SELL$5.8M
Nov 11, 2026
Meister Keith A.
Director
Nov 11, 2026
SELL$3.2M
Nov 11, 2026
Meister Keith A.
Director
Nov 11, 2026
SELL$236.1K
Nov 11, 2026
Meister Keith A.
Director
Nov 11, 2026
SELL$1.0M
Nov 11, 2026
Meister Keith A.
Director
Nov 11, 2026
SELL$1.9M
Nov 11, 2026
Meister Keith A.
Director
Nov 11, 2026
SELL$407.5K
Nov 11, 2026
Meister Keith A.
Director
Nov 11, 2026
SELL$1.1M
Nov 11, 2026
Meister Keith A.
Director
Nov 11, 2026
SELL$5.0M

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Reddit
Crowd this week 50° Neutral 0 bullish · 0 bearish
Mentions, 7 days 1 1 in posts · 0 in comments
Recent posts
All social signals and their track records

Short side

FINRA· Oct 30, 2026
8,021,680
shares short
+1.7%
vs prior settlement
3.7
days to cover
≈5.3%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 13, 2026 SEC
Capital World Investors filed an amended Schedule 13G disclosing a 6.7% passive stake in Illumina as of September 30…
SC 13G/A · Impact 3/10
Nov 12, 2026 SEC
Director Keith Meister sold approximately $35.8M of ILMN shares over three days (Nov 9-11) in open-market transactions…
CLUSTER · Impact 4/10
Nov 11, 2026 Insider
Meister Keith A. sold 26,950 shares
Director @ $215.48 ($5.8M)
Nov 11, 2026 Insider
Meister Keith A. sold 15,215 shares
Director @ $212.97 ($3.2M)
Nov 11, 2026 Insider
Meister Keith A. sold 1,103 shares
Director @ $214.02 ($236.1K)
Nov 10, 2026 SEC
Corvex Management LP, an affiliate of director Keith Meister, filed a Form 144 notice to sell 375,000 Illumina shares…
144 · Impact 4/10
Nov 2, 2026 Other
Illumina selected to help bring precision medicine into everyday healthcare in Singapore
SG-INSIGHT study will extend whole-genome sequencing to nearly 1 in 10 Singapore residents, generati
Oct 30, 2026 Event
In re Illumina, Inc. Consolidated Derivative Stockholder Litigation
Court ruling (delch). Docket: C.A. No. 2024-1337-PAF
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Nov 2, 2026
Press release
Illumina selected to help bring precision medicine into everyday healthcare in Singapore
SG-INSIGHT study will extend whole-genome sequencing to nearly 1 in 10 Singapore residents, generating evidence to inform how precision medicine…
Oct 30, 2026
Enforcement
In re Illumina, Inc. Consolidated Derivative Stockholder Litigation
Court ruling (delch). Docket: C.A. No. 2024-1337-PAF
Oct 29, 2026
Earnings
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2026
SAN DIEGO, Oct. 29, 2026 /PRNewswire/ -- Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the…
Oct 29, 2026
Earnings result
ILMN Q3 2026 Earnings: EPS $1.44 (+4.2% vs est)
Oct 27, 2026
Company news
Illumina To Webcast Upcoming Investor Conference
SAN DIEGO, Oct. 27, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that members of its management team will participate at the…
Congressional trades
ILMN trades disclosed by members of Congress, with disclosure delay.
1 members · 1 buys / 1 sells
DateMemberType AmountDisclosed
Oct 27, 2026 Gilbert CisnerosDHouse Illumina Inc SELL $1K–$15K Nov 10, 2026 +14d
Feb 10, 2026 Gilbert CisnerosDHouse Illumina Inc BUY $1K–$15K Mar 9, 2026 +27d

SecBot reports

29 filings · 6 bullish · 5 bearish · 1 mixed · 17 neutral
All ILMN filing & press-release reports (29)